--- title: "Ausun Pharm: Has repurchased a total of 5.2012 million shares, amounting to 50.006 million yuan" type: "News" locale: "en" url: "https://longbridge.com/en/news/263960530.md" description: "Ausun Pharm announced that as of October 31, 2025, the company has repurchased a total of 5.2012 million shares, with a total payment of 50.006 million yuan, and the repurchase price ranged from 7.52 yuan/share to 11.39 yuan/share. The repurchase plan was initiated on January 24, 2025, with an expected funding usage of 50 million to 100 million yuan, and the repurchase period will last until January 23, 2026. Due to the annual equity distribution in 2024, the upper limit of the repurchase price will be adjusted to no more than 13.90 yuan/share starting from July 17, 2025" datetime: "2025-11-03T07:54:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263960530.md) - [en](https://longbridge.com/en/news/263960530.md) - [zh-HK](https://longbridge.com/zh-HK/news/263960530.md) --- # Ausun Pharm: Has repurchased a total of 5.2012 million shares, amounting to 50.006 million yuan Ausun Pharm announced that on January 24, 2025, the company plans to repurchase shares through a share buyback proposal, intending to use 50 million to 100 million yuan of its own or raised funds for equity incentives and/or employee stock ownership plans, with the repurchase period ending on January 23, 2026. Due to the annual equity distribution in 2024, the upper limit of the repurchase price will be adjusted to no more than 13.90 yuan per share starting from July 17, 2025. As of October 31, 2025, the company has cumulatively repurchased 5.2012 million shares, accounting for 0.63% of the total share capital, with a total payment amount of 50.060 million yuan, and transaction prices ranging from 7.52 yuan per share to 11.39 yuan per share. No repurchase was implemented in October ### Related Stocks - [603229.CN](https://longbridge.com/en/quote/603229.CN.md) ## Related News & Research - [Missed payments and repo life](https://longbridge.com/en/news/284120450.md) - [19:52 ETRepurchases of shares by EQT AB during week 17, 2026](https://longbridge.com/en/news/284281769.md) - [RFK Jr.'s New Autism Committee Issues First Proposals](https://longbridge.com/en/news/284480897.md) - [07:16 ETChina's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth](https://longbridge.com/en/news/284557182.md) - [](https://longbridge.com/en/news/284610260.md)